Maya Fayfman1, Kristen Flint1, Shanthi Srinivasan2,3,4. 1. Emory University School of Medicine, Atlanta, GA, USA. 2. Emory University School of Medicine, Atlanta, GA, USA. ssrini2@emory.edu. 3. Atlanta Veterans Affairs Medical Center, Decatur, GA, USA. ssrini2@emory.edu. 4. Emory University, Rm 201, 615 Michael Street, Atlanta, GA, 30322, USA. ssrini2@emory.edu.
Abstract
PURPOSE OF REVIEW: The goal of the present review is to explore the relationship between dietary changes and alterations in gut microbiota that contribute to disorders of gut motility and obesity. RECENT FINDINGS: We review the microbiota changes that are seen in obesity, diarrhea, and constipation and look at potential mechanisms of how dysbiosis can predispose to these. We find that microbial metabolites, particularly short chain fatty acids, can lead to signaling changes in the host enterocytes. Microbial alteration leading to both motility disorders and obesity may be mediated by the release of hormones including glucagon-like peptides 1 and 2 (GLP-1, GLP-2) and polypeptide YY (PYY). These pathways provide avenues for microbiota-targeted interventions that can treat both disorders of motility and obesity. In summary, multiple mechanisms contribute to the interplay between the microbial dysbiosis, obesity, and dysmotility.
PURPOSE OF REVIEW: The goal of the present review is to explore the relationship between dietary changes and alterations in gut microbiota that contribute to disorders of gut motility and obesity. RECENT FINDINGS: We review the microbiota changes that are seen in obesity, diarrhea, and constipation and look at potential mechanisms of how dysbiosis can predispose to these. We find that microbial metabolites, particularly short chain fatty acids, can lead to signaling changes in the host enterocytes. Microbial alteration leading to both motility disorders and obesity may be mediated by the release of hormones including glucagon-like peptides 1 and 2 (GLP-1, GLP-2) and polypeptide YY (PYY). These pathways provide avenues for microbiota-targeted interventions that can treat both disorders of motility and obesity. In summary, multiple mechanisms contribute to the interplay between the microbial dysbiosis, obesity, and dysmotility.
Entities:
Keywords:
Constipation; Diarrhea; Dysmotility; Gut microbiome; Obesity
Authors: Kuppan Gokulan; Amit Kumar; Mohamed H Lahiani; Vicki L Sutherland; Carl E Cerniglia; Sangeeta Khare Journal: Toxicol Sci Date: 2021-02-26 Impact factor: 4.849
Authors: Marco Bernardi; Anna Lucia Fedullo; Elisabetta Bernardi; Diego Munzi; Ilaria Peluso; Jonathan Myers; Florigio Romano Lista; Tommaso Sciarra Journal: World J Gastroenterol Date: 2020-05-28 Impact factor: 5.742